Противовирусный препарат Кагоцел и новый коронавирус SARS-CoV-2 (COVID-19)

Kagocel Supports the Russian Team at the Eurohockeytour

Winter sports are known for their spectacularity. Traditionally, during the snow season we closely watch our hockey players and figure skaters so that we don’t miss triumphantly scored goals, triple toe loops and fantastic supports. This season, Kagocel supports not only figure skaters at the European Championship, but our hockey players, who will participate in the European tour. 

From November 8 through December 17, games in the framework of the Karjala Cup and the Channel One Cup will take place, with the participation of teams from Russia, Canada, Finland, Czech Republic, Sweden, Switzerland and South Korea. The Euro tour is an annual ice hockey tournament held during pauses in the national championships. It also serves as a kind of preparation for the world championships and the Olympics. Kagocel will support our team on the way to new victories, because an athlete should always be in great shape, which includes protection from viruses of cold and flu, and powerful immunity.  

Reference: 
Kagocel is an original antiviral drug developed by Russian scientists for the treatment and prevention of influenza and ARVI for adults and children from 3 years of age. The drug is sold without a doctor's prescription, it possesses a high safety profile and a convenient regimen. The effectiveness of Kagocel is confirmed by registration clinical studies conducted to assess the therapeutic efficacy and safety for adults and children from 3 years.




← Back to the list

OUR AWARDS